Analysts Set Astrana Health, Inc. (NASDAQ:ASTH) Target Price at $65.17

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given a consensus rating of “Buy” by the eight ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $65.17.

A number of research firms have commented on ASTH. TD Cowen started coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. BTIG Research lifted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. KeyCorp initiated coverage on shares of Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Stifel Nicolaus boosted their price objective on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Finally, Robert W. Baird increased their target price on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th.

Institutional Investors Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently made changes to their positions in ASTH. GAMMA Investing LLC bought a new position in Astrana Health during the 3rd quarter worth $34,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth $35,000. KBC Group NV bought a new position in shares of Astrana Health in the third quarter worth $70,000. Quarry LP acquired a new position in Astrana Health in the third quarter valued at about $77,000. Finally, Quest Partners LLC acquired a new position in Astrana Health in the third quarter valued at about $133,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Trading Up 0.9 %

Shares of NASDAQ:ASTH opened at $42.86 on Friday. Astrana Health has a 52-week low of $32.32 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market capitalization of $2.41 billion, a P/E ratio of 32.97, a price-to-earnings-growth ratio of 1.97 and a beta of 1.24. The company has a 50-day simple moving average of $53.37 and a 200 day simple moving average of $47.95.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. During the same quarter in the prior year, the company earned $0.47 earnings per share. Sell-side analysts forecast that Astrana Health will post 1.17 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.